Speaker - Elli Kaplan

 Elli  Kaplan  Thumbnail


Neurotrack is developing a cognitive test that can detect the first neurological effects of Alzheimer’s, up to six years before the onset of behavioral symptoms. Early diagnosis is a great advantage for patients, giving them time to plan and take steps that can delay the onset of the disease. Before cofounding Neurotrack, Elli Kaplan worked in the public sector and held senior positions with AIG Capital Partners and Goldman Sachs, as well as several startups.

1 Program

Little Companies, Big Solutions

11.06.13 | 00:36:11 min | 0 comments